Fig. 4From: Ganglioside-monosialic acid (GM1) for prevention of chemotherapy-induced peripheral neuropathy: a meta-analysis with trial sequential analysisForest plot displaying a random-effects meta-analysis of the effect of GM1 on the incidence of grade ≥ 2 oxaliplatin-induced peripheral neuropathy using the Neurotoxicity criteria of Debiopharm (DEB-NTC)Back to article page